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Low birth weight is associated with reduced bone mass and density in adult life. However, effects of maternal hypoxia (MH) on
offspring bone development are not known.Objective. The current study investigated the effects of fetal growth restriction induced
by MH during the last half of gestation on bone structure and volume in the offspring of the fetus near term and the pup in
adolescence.Methods. During 35–62-day gestation (term, 69d), guinea pigs were housed in room air (21% O
2
; control) or 12% O
2
(MH). Offspring femur and tibia were collected at 62d gestation and 120d after birth. Results. MH decreased fetal birth weight
but did not affect osteogenic potential pools in the fetal bone marrow. Histological analysis showed no effects of MH on tibial
growth plate thickness in either fetal or postnatal offspring, although there was increased VEGF mRNA expression in the growth
plate of postnatal offspring. MH did not change primary spongiosa height but lowered collagen-1 mRNA expression in postnatal
offspring. There was increased mRNA expression of adipogenesis-related gene (FABP4) in bone from the MH postnatal offspring.
Conclusion. MH during late gestation did not change the pool of osteogenic cells before birth or growth plate heights before and
after birth. However, MH reduced expression of bone formation marker (collagen-1) and increased expression of fat formation
marker (FABP4) in postnatal offspring bone.
1. Introduction
Body composition and musculoskeletal development begin
in embryonic life, when bone and muscle develop from
the mesodermal layer. Longitudinal bone growth before and
after birth takes place in the growth plate located at the
epiphyses of long bones via an endochondral ossification
process in which a hypertrophic cartilage template is made,
calcified, and invaded by blood vessels and then converted
to trabecular bone through the action of bone forming cells,
osteoblasts, and bone resorbing cells, osteoclasts [1]. Bone
mass and bone size increase throughout childhood, reaching
their peak at the end of adolescence, when growth plates are
closed [2, 3]. While optimal bone growth achieved during
childhood is critical both for ensuring optimal development
and protection from fractures during childhood, evidence is
growing that peak bonemass is also an important contributor
to bone mass and strength in later life [4]. Peak bone mass
is a predictor of the age of onset of osteoporosis and a
determinant of osteoporotic fracture risk in the elderly [5–8],
a skeletal disorder associated with a progressive decrease in
bonemineral density (BMD) and an increase in bone fragility
and susceptibility to fractures.
There are a range of endocrine and paracrine factors that
regulate bone growth [1]. Alterations to the diet of pregnant
animals can produce lasting changes in the phenotype,
physiology, and metabolism of the offspring [9–12]. This
results in a range of adaptations that occur in response
to the reduced substrate supply and have been shown to
permanently program its physiology and metabolism [11,
13]. Fetal growth restriction can be caused by maternal
undernutrition, maternal hypoxia (MH), maternal smoking,
and placental insufficiency [13, 14]. Placental insufficiency
and MH both result in fetal hypoxemia during the latter part
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of pregnancy [15, 16]. Studies have shown that birth weight is
associated with bone mass, and low birth weight is related to
a low bone mineral content in adults and increased fracture
risks later in life [17–19]. However, the role of hypoxia on bone
formation/remodelling is unclear.
In multicellular species, local oxygen partial pressure
represents the functional regulator of oxygen homeostasis in
the lung, blood, and other tissues. Insufficiency of oxygen can
result in a failure to generate sufficientATP tomaintain essen-
tial cellular functions [18]. In physiological circumstance
or pathological conditions, a program of gene expression
changes is induced by hypoxia-inducible factor-1 (HIF-1).
HIF-1 controls hypoxic expression of genes with metabolic
functions such as glucose transport and metabolism and
angiogenic factors like vascular endothelial growth factor
(VEGF). As a subunit of HIF, HIF-𝛼 is a hypoxically
responsive component. Studies have suggested that induced
hypoxia in mouse and rabbit embryos leads to a variety
of developmental defects that occur in places including the
heart and vertebral column [17, 19, 20]. Furthermore, smok-
ing during pregnancy, which causes fetal hypoxemia, may
suppress bone matrix synthesis and mineralisation during
gestation with lower osteocalcin levels in the umbilical blood
in neonates of smoking mothers [20]. In vitro studies with
human mesenchymal stem cells exposed to reduced oxygen
tension demonstrated delayed osteoblast maturation, shown
by reduced mRNA expression of osteocalcin and type 1
collagen (Cola1). However, it appears that the timing and the
extent of the hypoxia influence the type of developmental
process that is disrupted [21].
We hypothesised thatMHwould result in decreased bone
development in the fetus and thus reduced bone mass in
adolescence. The current study examined the effects of fetal
growth restriction induced by MH during the last half of
gestation on bone structure and volume in the offspring
before and after birth.
2. Materials and Methods
2.1. Animals. All procedures were approved by the Animal
Ethics Committees at the University of South Australia
(IMVS) and the University of Adelaide. IMVS tricoloured
guinea pigs were individually housed at 18–22∘C and in a
12/12 light cycle. All animals were fed standard laboratory
rabbit/guinea pig chow (Laucke Mills, Daveyston, Australia)
with ad libitum access to water supplemented with 0.5 g/L
Vitamin C. Breeding females (sows) were weighed and given
a known weight of food three times weekly. The remaining
food was weighed to determine food intake per gram of
body weight. After 4–6 weeks of controlled feeding, breeding
females were placed with a male for 24 h and were mated.
Females in oestrus were placed with a male overnight and
pregnancy was detected by the presence of a vaginal copu-
latory plug the following morning and a failure to return to
oestrus in the subsequent cycle [22, 23].
2.2. Experimental Protocol and Specimens. At 35d gestation,
pregnant sows were randomly assigned to control or MH
groups. Sows assigned to MH were housed in 12% oxygen
(half of normal % of oxygen in air [24]) with ad libitum access
to food. For fetal studies (𝑛 = 5), MH continued until sows
and fetuses were humanly killed at 62d gestation (term, ∼
69d)with an overdose of sodiumpentobarbitone (325mg/mL
pentobarbitone sodium; Virbac Pty Ltd., Peakhurst, Aus-
tralia). For postnatal studies (𝑛 = 5), MH continued until
65d gestation, whereupon pregnant sows were returned to
normoxia (21% oxygen in air), to ensure pups were born into
normoxia. All sows and pups were exposed to normoxia with
ad libitum access to food during lactation and postweaning.
Pups were weaned at 28d and subsequently housed in same
sex pairs until humanely killed at 120d (adulthood [25]) with
a sodium pentobarbitone overdose as above.
The left tibias from each fetus and pup were collected,
fixed in 10% formalin, and decalcified in Immunocal solution
(Decal Corporation, Tallman, NY) for 14d at 4∘C prior to
being bisected longitudinally and processing for paraffin wax
embedding and sectioning (4 𝜇m).The right tibia was used to
collect growth plate and metaphysis bone samples that were
frozen in liquid nitrogen and stored at −80∘C until being
used for RNA extraction and gene expression analysis. Bone
marrow cells were collected from the fetal femurs by flushing
with basal cell culture medium as described [26].
2.3. Histomorphometric Analysis of Growth Plate and Meta-
physeal Bone. To examine treatment effects on bone growth,
bone structure, and volume, H&E-stained proximal tibial
sections were used for basic histomorphometric measure-
ments including growth plate thickness, primary spongiosa
height, and secondary trabecular bone volume (BV/TV) as
previously described [27, 28] and total adipocyte counts
(number/mm2 bone marrow area) in lower secondary spon-
giosa as previously described [26].
2.4. Colony Forming Unit-Fibroblast Assay. To determine
treatment effects on the size of the osteoprogenitor cell pool,
a colony forming unit-fibroblast (CFU-f) assay and alkaline
phosphatase (ALP, an osteoprogenitor cell marker) staining
were performed with bone marrow cells obtained from fetal
femurs as described [29]. Briefly, isolated bone marrow
cells were plated at 2 × 106 mononuclear cells (MNCs)/well
in 6-well tissue culture dishes with complete medium (𝛼-
MEM supplemented with 10% FBS, 50𝜇g/mL Pen/Strep,
15mMHEPES, and 100 𝜇M L-ascorbic acid-2-phosphate).
Cells were cultured for 14d with media changed every 3d. At
the end of culture, cells were fixed with 4% paraformaldehyde
and stained for ALP using a kit (Roche Biochemicals, Sydney,
Australia). The number of positive colonies (osteoprogenitor
cell pool in the bone marrow) was expressed as CFU-f ALP+
colonies per 2 × 106 MNCs.
2.5. Real-Time Reverse Transcriptase Polymerase Chain Reac-
tion (RT-PCR). Frozen growth plate and metaphyseal bone
specimens were ground to fine powder with liquid nitrogen
using a mortar and pestle, and total RNA was extracted
using TRI reagent (Sigma, NSW, Australia). To generate
the template for PCR amplification, 2 𝜇g of metaphyseal
RNA was reverse transcribed into cDNA using the high
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Table 1: Effects of MH on body weights of fetal guinea pigs at 62 d
gestation and postnatal guinea pigs at day 120. Values are means (±
SEM), 𝑛 = 5.
Treatment Fetal Guinea Pig Post natal Guinea Pig
Control Hypoxic Control Hypoxic
Body weight,
grams (sem) 84.4 (3.5) 66.9
∗ (2.2) 869.2 (50.9) 858.4 (44.3)
∗
𝑃 < 0.05 when compared to control.
capacity RNA-to-cDNA kit (Applied Biosystems, Foster City,
CA). All PCR primers (Table 2) were designed using guinea
pig DNA sequences and NCBI PRIMER BLAST software
and supplied by GeneWorks (Adelaide, SA, Australia). For
quantitative RT-PCR of genes of interest (Table 2), a real-
time PCR reaction of 10 𝜇L was set up using SYBR1 Green
master mix (Applied Biosystems). For each cDNA sample,
quantitative PCR assays were run on a 7500 Fast Real-Time
PCR System (Applied Biosystems) in duplicate. From the
amplification curves, relative expression was calculated using
the comparative 2−ΔΔCT method, with cyclophilin A serving
as the endogenous control as described [26].
2.6. Statistical Analysis. Data are presented as means ± SEM
andwere analysed using an unpaired Students’ t-test andwere
nested for litter using STATA10 (StataCorp, TX, USA). 𝑃 <
0.05 was considered significant.
3. Results
3.1. MH Decreased Offspring Body Weight. MH resulted in
reduced fetal body weight at 62d gestation compared to
fetuses from controlmothers (𝑃 < 0.05; Table 1). However, by
120d after birth, there were no differences in body weight
between treatment groups.
3.2. MH Did Not Change Growth Plate Thickness. Histomor-
phometric measurements demonstrated that MH did not
alter tibial growth plate total thickness in either fetal or
postnatal offspring compared to controls (Figures 1(a)–1(d),
𝑃 > 0.05). There was no effect of MH on zonal heights of
the growth plate in either the fetal or postnatal tibial bone
(Figures 1(c) and 1(d)).
3.3. Gene Expression of Chondrocyte Maturation Markers.
The mRNA expression of the key angiogenic growth fac-
tor, VEGF, was significantly higher in the growth plate of
postnatal offspring exposed to MH compared to controls
(Figure 2(a)). However, there were no differences in the
mRNA level of hypoxia-induced factor (HIF-1𝛼) between
offspring from the MH and control groups (Figure 2(b)).
MH did not affect levels of mRNA expression of collagen
type X (Col10) and matrix metalloprotease-9 (MMP-9), both
involved in the maturation of the growth plate cartilage and
its bone conversion (Figures 2(c) and 2(d)).
3.4. MH Did Not Change Primary Spongiosa Height of Meta-
physis. To examine the effect of MH on endochondral bone
formation, heights of primary spongiosa (newly derived from
calcified growth plate cartilage) were measured (Figures 3(a)
and 3(b)). MH did not affect the primary spongiosa height of
fetal (Figure 3(c)) or postnatal offspring compared to controls
(Figure 3(d); 𝑃 > 0.05).
3.5. Effects of MH on Bone and Bone Marrow Fat Volumes.
Metaphyseal trabecular bone volume was analysed in the
secondary spongiosa, which is composed of enlarged min-
eralized bony trabeculae modelled or remodelled from the
primary spongiosa. There were no significant differences in
bone volume (BV/TV %) in fetal (Figure 4(a)) or postnatal
(Figure 4(c)) offspring of MH compared to control mothers.
When the bone volume was adjusted for body weight (bone
volume/body weight), the relative bone volume was higher in
MH compared to control fetuses (Figure 4(b); 𝑃 < 0.05), but
not postnatal offspring (Figure 4(d)).
There were no adipocytes in the bone marrow in fetal
guinea pigs (Figure 5(a)). There was no effect of MH on
marrow adiposity in postnatal offspring of MH compared to
control mothers (Figures 5(b), 5(c), and 5(d)).
3.6. MH Did Not Change Osteogenesis but Increased Adipo-
genesis-Related Gene Expression. Bone sialoprotein (BSP)
gene expression in the metaphysis of postnatal offspring was
not affected by MH (Figure 6(a)). However, MH offspring
had a lower level of collagen-1 (Cola1) mRNA expression
compared to control offspring after birth (𝑃 < 0.05;
Figure 6(b)). While there were no significant changes in
mRNA expression of the adipogenic transcription factor,
peroxisome proliferator-activated receptor gamma (PPAR𝛾;
Figure 6(c)), MH induced an increase in mRNA expression
of fatty acid binding protein 4 (FABP4) in the postnatal
offspring (Figure 6(d)).
3.7. MH Did Not Change the Size of the Bone Marrow
Osteoprogenitor Cell Pool. CFU-f assay and ALP staining
were carried out with bone marrow samples from the fetal
guinea pigs to examine the osteoprogenitor cell pool in the
bonemarrow (Figure 7).Therewere no significant differences
in the osteoprogenitor pool size in fetal offspring of mothers
from both groups.
4. Discussion
One of the main consequences of fetal growth restriction
is low birth weights with low bone mass [30, 31]. Popula-
tion studies have demonstrated that there are associations
between weight at 1 year and adult bone mineral contents at
lumbar spine and femoral neck as well as adult bone mass
[19, 32–34].There is also evidence that fetal growth restriction
results in an increased risk of osteoporotic fracture [18, 35],
suggesting that the lack of nutrients early in life may compro-
mise adult skeleton. The present study has shown that MH
caused a significant reduction in fetal weight. MH did not
change the growth plate thickness, despite increased mRNA
expression of VEGF in postnatal offspring. Histological and
gene expression studies suggest that MH also reduced bone
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Table 2: Primer pairs used in this study.
Gene Forward primer Reverse primer









































Figure 1: Effects of MH on total thickness and zonal heights in the growth plate of offspring. H&E-stained tibial sections (showing growth
plate height) of 120d postnatal guinea pigs from a control (a) and a hypoxic (b) mother, respectively.The dashed lines in (a) and (b) arbitrarily
separate the three individual growth plate zones. (c) Total growth plate thickness and zonal heights (resting, black bar; proliferative, grey bar;
hypertrophic, white bar) of 62d gestation fetal guinea pigs from control and hypoxia-treated mothers. (d) Total growth plate thickness and
zonal heights of 120d postnatal guinea pigs from control and hypoxia-treated mothers (𝑛 = 5). Scale bar in (a) = 250 𝜇m and applies to (b).
formation potential and a potential increase in bone marrow
adiposity (increased FABP4 mRNA expression) in postnatal
offspring in this model.
4.1. Effects of Maternal Hypoxia on Histology and Gene
Expression in the Growth Plate of Postnatal Offspring. MH
caused fetal growth restriction, but offspring weight was
accelerated in postnatal life such that by 120d of age offspring
in the control andMHgroupwere the sameweight. However,
MH had no effect on tibial growth plate thickness or primary
spongiosa heights, two regions that aremainly responsible for
bone lengthening and bonemass accumulation before or after
birth.



















































































Figure 2: Effects of MH on mRNA expression of genes in growth plate in the postnatal offspring. Quantitative real-time RT-PCR expression
data for VEGF (a), HIF-1𝛼 (b), Col10 (c), and MMP-9 (d) are expressed as relative to internal standard cyclophilin A. ∗𝑃 < 0.05 when
compared to control.
There was no change in HIF-1𝛼 mRNA expression in
MH postnatal offspring. There were, however, changes in
the expression of some but not all genes that are regulated
by HIF-1𝛼. Interestingly, there was a significant elevation in
the expression of VEGF in MH postnatal offspring. VEGF is
induced by the hypoxia-mediated control of gene expression
(particularly HIFs) [36, 37] and induces angiogenesis. Our
finding of increased VEGF expression is consistent with a
previous study where hypoxia increased VEGF production
in osteoblasts [38, 39]. HIF-mediated functions assure the
differentiation of progenitor cells when the cells are exposed
to hypoxic conditions during chondrogenic or osteogenic
differentiation in embryo development [40]. It has been
shown that placental insufficiency can result in nonphysio-
logical hypoxia, and it appears that timing and extent of the
deficiency determine the type of developmental process that
is disturbed [41]. In the current study, levels of expression
of HIF-1𝛼 in the growth plate of the postnatal offspring
of hypoxic mothers remained unchanged, suggesting that
the extent of hypoxia did not cause an upregulation of the
hypoxic responsive transcription factor. However, further
work investigating the protein levels of HIF-1𝛼 is required
to understand the mechanism behind the observed increase
in VEGF mRNA expression. In addition, MH did not affect
expression of gelatinase or MMP-9 (another downstream
target gene of HIF-1𝛼) in the growth plate of offspring. Both
VEGF and MMP-9 have been shown to play a central role
in embryonic bone development and bone remodelling. The
lack of effects of MH on HIF-1𝛼 and MMP-9 expression may
be related to the extent and duration of MH of the current
study which may not have yielded an adequate in utero
stimulus able to alter bone development in the offspring. In
addition, the lack of effects could also be due to normalisation
of their expression postnatally.
Consistent with the lack of an effect of MH on MMP-
9 mRNA expression and the height of the growth plate and
primary spongiosa, MH did not change the expression of
another hypertrophic cartilage marker Col10 in the growth
plate of fetal or postnatal offspring. Thus, while it is difficult
to determine whether MH in the current study may have
delayed chondrocyte hypertrophy and endochondral bone
development, it is possible that MH of a greater severity or


















Postnatal primary spongiosa height (𝜇m)
(d)
Figure 3: Effects of maternal hypoxia on offspring proximal tibia primary spongiosa height. (a) and (b) H&E-stained tibial sections (primary
spongiosa shown between two tracing lines) of 120d postnatal guinea pigs from a control and a hypoxic mother, respectively. (c) Primary
spongiosa height of (c) 62d gestation fetal and (d) postnatal 120d guinea pigs from control and hypoxia-treated mothers (𝑛 = 5). Scale bar in
(a) = 1mm and applies to (b).
a longer duration may have had a significant effect. Although
in vitro studies have demonstrated that high oxygen tensions
favour the hypertrophic differentiation of chondrogenic cul-
tures or tissues [42, 43] associated with a possible increase
in the expression of the hypertrophic cartilage marker genes,
MMP13, and collage type 10 [44], a possibility for the lack
of significant differences in the current model is adaptation,
which has been previously shown in rabbit heart [45].
4.2. Effects of Maternal Hypoxia on Bone Structure in the
Postnatal Offspring. There was no effect of MH on trabecular
bone histological measurements in the long bones of postna-
tal offspring, which may further support the importance of
the postnatal environment in contributing to the growth and
development of the offspring. Some of the negative effects of
fetal growth restriction on postnatal health can be rescued
by the provision of a normal lactation environment [46],
demonstrating that the postnatal environment is also influ-
ential in long-term bone health outcome [46]. The variable
long-term effects of low birth weight on bonemineral density
or hip fracture risk later in life suggest other contributing
factors such as physical activity and nutrition may have a
more substantial role in determining hip fracture risk [47].
These studies further suggest that bone mass at adulthood
rather than at adolescence may be more important in deter-
mining the effects of MH and the onset of osteoporosis.
4.3. Effects ofMaternal Hypoxia in the BoneMarrowAdiposity.
MH in the current model did not change adipocyte contents
or expression of the key adipogenesis-related gene PPAR𝛾;
there was an increase in the mRNA expression of FABP4
and decrease in the mRNA expression of the bone formation
marker Cola1 (despite a lack of change in bone volume
fraction) in the metaphysis bone. These results suggest that
although the bone volume fraction may have recovered
from the in utero hypoxia as they were placed in normal
normoxic environment postnatally, MH may have caused
some permanent damage in the metaphysis that may have
consequences later in life. Adipocytes and osteoblasts share
a common stromal precursor in the bone marrow [48] and
it has been suggested that there is a potential switch in dif-
ferentiation of bone marrow stromal progenitor cells towards
































Relative postnatal bone volume (%)
(d)
Figure 4: Effects of MH on tibial trabecular bone volume as measured by histomorphometry (BV/TV, %). (a) BV/TV of fetal bones from
control and hypoxia-treated mothers. (b) Relative BV/TV (adjusted for total body weight) in fetal guinea pigs (%/g). (c) BV/TV of bones of
120d postnatal guinea pigs from control and hypoxia-treated mothers. (d) Relative BV/TV in postnatal guinea pigs (adjusted for total body
weight, %/g). (𝑛 = 5, ∗𝑃 < 0.05 when compared to control).
adipogenesis at the expense of osteogenesis in response to
damages/stress [49]. This suggests that this mechanism may
be present in the MH offspring, which is supported by the
increase in mRNA expression of the adipogenesis-related
gene FABP4 and the reciprocal reduction in the expression
of the osteogenesis gene Cola1 in the bone. Previously, long-
termMH in sheep increasedmRNAexpression of PPAR𝛾 and
its coactivator (PGC1𝛼) mRNA in perirenal adipose tissue in
late gestation [50], suggesting that there is an effect of hypoxia
on adipogenesis in both bone marrow and extraosseous
adipose tissues. These studies suggest that MH in the current
setting may not be as detrimental to the bone and bone
marrow as demonstrated by the lack of effects of MH on fetal
guinea pigs.
4.4. Effects of Maternal Hypoxia on the Size of Fetal BoneMar-
row Osteoprogenitor Cell Pool. MH did not change bone his-
tomorphometry in fetal offspring, suggesting that osteogenic
differentiation potential of bone marrow progenitor cells
(ALP+ CFU-F colonies formed) was not affected by MH.The
effect of MH on the osteogenic potential in the fetal offspring
has not previously been studied. Several in vitro studies have
demonstrated a negative effect of hypoxia on cell growth [39,
51] and osteogenic differentiation [21, 51], while others have
shown a positive outcome for osteoblastic differentiation [52].
Hypoxia (2% oxygen) inhibited proliferation and delayed
osteoblast differentiation of immature calvarial osteoblast
precursors from neonatal rats [53]. In addition, hypoxia
inhibited mineralised nodule formation by osteoblasts at
both early and late stages of culture, which recovered well
when cells were transferred to normal O
2
levels after early





conditions on differentiation potential
of osteoblasts but diminished osteoblastic differentiation
at 0.02% O
2
[21]. These inconsistent studies suggest that
















Figure 5: Effects of MH on numbers of adipocytes in the lower secondary spongiosa of tibial bone. (a) Bone marrow in fetal guinea pigs does
not contain adipocytes (a section from a control fetal guinea pig). Bone marrow showing presence of adipocytes in a day 120 postnatal guinea
pig from a control (b) and a hypoxic mother (c). (d) Bone marrow adipocytes/mm2marrow area from control and hypoxia-treated mothers.
𝑛 = 5. Scale bar in (a) = 500 𝜇m and applies to (b) and (c).
effects of exposure to hypoxia of mesenchymal stem cells or
osteoblastic cells may be time and dose dependent.
In summary, some previous studies have suggested that
adverse influences, arising in fetal life or immediately after
birth, may have an important effect on later risk of lower
bone mass or osteoporotic fracture. We have demonstrated
that MH during pregnancy in this model does not change
growth plate and bone structures in offspring before and after
birth. However, gene expression studies suggest thatMHmay
have damaged the bone as demonstrated by an upregulation
of genes involved in fat formation and a reciprocal down-
regulation of the genes involved in bone formation despite
the lack of obvious changes in bone volume and adipocyte
content in the postnatal bone marrow in this model. Further
studies investigating the effects of maternal insufficiencies
during the different stages of prenatal development and
postnatal growth in offspring would increase our under-
standing of the consequences on offspring bone development
and identify the crucial time points whereby changes in
growth plate, bone, and bone marrow can be observed.
Further investigations should be performed to determine if
intrauterine insults can be rescued with postnatal nutritional
interventions which may lead to the prevention of adult
diseases such as osteoporosis.
5. Limitations
The current study has raised many questions which require
further investigations. As the current study was limited to
only observe the effects of maternal hypoxia at one point after
birth, a future study should be carried out using the current
model but with different observation time points such as 1,
3, and 5 months postnatally. This will further explain the
influence of maternal hypoxia on bone development at differ-
ent stages of skeletal development postnatally. Furthermore,
although the bone volume in the current model was found
to be not compromised by maternal hypoxia, biomechanical
studies looking at the breaking strength of long bones as
well as measurements of bone mineral contents (as measured
by the ash weight of bone samples) should be employed to
fully understand the effects of maternal hypoxia on the bone
development in their offspring. Moreover, further studies
should be carried out to investigate the proliferation and
differentiation potentials of the marrow progenitor cells













































































Figure 6: Effects of MH on mRNA expression of genes in the metaphysis bone of postnatal offspring. Quantitative real-time RT-PCR
expression data for BSP (a), Cola1 (b), PPAR𝛾 (c), and FABP4 ((d), 𝑃 = 0.05) are expressed relative to internal standard cyclophilin A.
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Figure 7: Effects of MH on the osteoprogenitor cell pool in bone
marrow of fetal guinea pigs. Data showing the number of CFU-
f colonies stained positive for alkaline phosphatase (ALP) in total
bone marrow mononuclear cell population (values are means ±
SEM, 𝑛 = 5).
isolated from the offspring of hypoxic mothers. In addition,
the protein expression of HIF-1𝛼 should also be investigated
as it provides a clearer understanding as to whether a hypoxic
environment in the bone marrow environment would have
been created by maternal hypoxia in bone. Similarly, the
sources (or cell types) of expression of key factors particularly
RANKL, TNF-𝛼 and IL-1, and OCN should be investigated
(e.g., by immunohistochemistry) to get more insights into




BMD: Bone mineral density
HIF-1: Hypoxia-inducible factor-1
VEGF: Vascular endothelial growth factor
Cola1: Type 1 collagen
BV/TV: Trabecular bone volume
CFU-f: Colony forming unit fibroblast
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MNCs: Mononuclear cells
RT-PCR: Real-time reverse transcriptase polymerase
chain reaction
Col10: Collagen type X
MMP-9: Matrix metalloprotease 9
PPAR𝛾: Peroxisome proliferator-activated receptor
gamma
FABP4: Fatty acid binding protein 4.
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